arrow
V

Víctor Galán-Gómez

pediatric hemato-oncology department
H指数:7
被引数:317

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bridging therapy in pediatric and AYA patients under 25 years with relapsed/refractory B-ALL undergoing anti-CD19 CAR-T therapy: a multicenter retrospective study by the Spanish group GETH-TC

25岁以下复发/难治性B-ALL儿科及青少年成年过渡期患者接受抗CD19 CAR-T治疗时的桥接治疗:西班牙GETH-TC多中心回顾性研究

2026-10-120
PRE
Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy

Tisa-cel和axi-cel CAR结构影响CD19-CAR-T疗法耐药性的发展

Leukemia
IF13.4
2026-08-270
OA
Transfusion-related pulmonary complications in paediatric acute myeloid leukaemia: A case report of transfusion-associated circulatory overload (TACO) and transfusion-related acute lung injury (TRALI)

输血相关肺并发症在儿童急性髓系白血病中的案例报告:输血相关循环超负荷(TACO)和输血相关急性肺损伤(TRALI)

2026-01-010
PRE
Ex Vivo IL-15-Stimulated NK Cells as Adoptive Cell Therapy in Haploidentical Transplantation for Pediatric Leukemia

异体移植中用于儿童白血病的离体IL-15刺激的NK细胞作为过继细胞疗法

2025-08-080
PREAI
Tandem CD19/CD22 CAR T-cells as potential therapy for children and young adults with high-risk r/r B-ALL

串联CD19/CD22 CAR T细胞作为儿童和年轻高风险复发/难治性B-ALL的潜在治疗方法

2025-08-050
OA
IEIVariantFilter: a bioinformatics tool to speed up genetic diagnosis of inborn errors of immunity patients

IEIVariantFilter:一个用于加速免疫性先天性错误患者遗传诊断的生物信息学工具

2025-05-280
OA
CD19 CAR-T cell therapy in a pediatric patient with MDA5+ dermatomyositis and rapidly progressive interstitial lung disease

CD19 CAR-T细胞疗法在一名MDA5⁺皮肌炎伴快速进展性间质性肺病的儿科患者中的应用

Med
IF11.8
2025-04-290
PRE
Safety and Efficacy of High-Dose Memory CD45RO+Donor Lymphocyte Infusion in Pediatric Recipients after Hematopoietic Stem Cell Transplantation
2024-12-011
PRE
Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring (vol 14, 1280580, 2024)
2024-02-070
OAAI
Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring
2024-01-169
OAAI
Executive functions and behavioral outcomes after CAR-T cell therapy. A case report in the context of the psycartkids project

Car-t细胞治疗后的执行功能和行为结果。psycartkids项目背景下的案例报告

2023-12-010
PRE
Treosulfan-Based Conditioning Regimen In Pediatric Hematopoietic Stem Cell Transplantation: A Retrospective Analysis on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)

小儿造血干细胞移植中基于Treosulfan的预处理方案: 代表西班牙造血移植和细胞治疗小组 (geth-tc) 的回顾性分析

2023-11-011
OAAI
CD19+lineage chimerism, an early biomarker after anti-CD19 CAR-T cell therapy in patients previously receiving a hematopoietic stem cell transplantation

CD19谱系嵌合体,在先前接受造血干细胞移植的患者中anti-CD19 car-t细胞治疗后的早期生物标志物

2022-08-082
OAAI
Advanced Molecular Characterisation in Relapsed and Refractory Paediatric Acute Leukaemia, the Key for Personalised Medicine

复发和难治性小儿急性白血病的高级分子表征,个性化医学的关键

2022-05-271
OAAI